Momenta Pharma (MNTA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2004 | 12-2003 | 12-2002 | |
| Assets | |||
| Current Assets | |||
| Cash & Cash Equivalents | 11,678 | 4,613 | N/A |
| Marketable Securities | 41,943 | 7,994 | N/A |
| Receivables | 5,039 | 2,018 | N/A |
| TOTAL | $60,116 | $14,887 | $N/A |
| Non-Current Assets | |||
| PPE Net | 2,723 | 1,117 | N/A |
| Other Non-Current Assets | 1,491 | 80 | 0 |
| TOTAL | $4,214 | $1,197 | $N/A |
| Total Assets | $64,330 | $16,084 | $N/A |
| Liabilities | |||
| Current Liabilities | |||
| Short Term Debt | 715 | 321 | N/A |
| Accounts payable and accrued liabilities | 3,489 | 804 | 0 |
| Accrued Expenses | 1,611 | 571 | N/A |
| TOTAL | $5,962 | $1,843 | $N/A |
| Non-Current Liabilities | |||
| Long Term Debt | 1,105 | 372 | N/A |
| Deferred Revenues | 147 | 147 | N/A |
| Other Non-Current Liabilities | 0 | 6 | 0 |
| TOTAL | $1,375 | $795 | $N/A |
| Total Liabilities | $7,337 | $2,638 | $N/A |
| Shareholders' Equity | |||
| Shares Outstanding, K | 25,483 | N/A | N/A |
| Common Shares | 3 | N/A | N/A |
| Retained earnings | -51,944 | -15,628 | N/A |
| Other shareholders' equity | -3,576 | 24,114 | 0 |
| TOTAL | $56,993 | $13,446 | $N/A |
| Total Liabilities And Equity | $64,330 | $16,084 | $0 |